Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
PlexusDx provides a direct path to semaglutide therapy without waiting for insurance approval or navigating pharmacy shortages
Its proven to target the real root cause of uncontrollable weight gain and melt fat faster than traditional diets, exercise or dangerous injections, a sales email said
Then, each of six redox metabolites is measured in cyclic enzymatic assay system, followed by colorimetric analysis